In the future, according to the contract signed between Hebang Hong Kong and AEV, AEV will be allocated to Hebang Hong Kong in two stages at an issue price of 0.006 Australian dollars per share, with a total subscription amount of Hebang Hong Kong of about 4.5 million Australian dollars. After completing the corresponding placement and the reorganisation of the board of directors and management, Hebang Hong Kong will absorb AEV as a holding subsidiary and provide it with interest-bearing loans to complete the development of the phosphate project as soon as possible.
https://www.hebang.cn/index/shows/35/625.html
straight from the hebang announcement but not in the Avenira one, interest bearing loans to complete the development of the phosphate project as soon as possible.
that seems like a rather glaring omission from the asx ann
- Forums
- ASX - By Stock
- Ann: Strategic Investment from Sichuan Hebang Biotechnology
In the future, according to the contract signed between Hebang...
-
- There are more pages in this discussion • 192 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AEV (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $24.33M |
Open | High | Low | Value | Volume |
0.9¢ | 0.9¢ | 0.9¢ | $2.52K | 280K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 2636788 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 519990 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 2636788 | 0.009 |
7 | 720000 | 0.008 |
4 | 1442142 | 0.007 |
8 | 21007328 | 0.006 |
2 | 1500001 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 519990 | 3 |
0.011 | 1683566 | 4 |
0.012 | 559923 | 5 |
0.013 | 152257 | 2 |
0.014 | 2440000 | 5 |
Last trade - 10.43am 13/11/2024 (20 minute delay) ? |
Featured News
AEV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online